Results 81 to 90 of about 23,927 (264)

Clonal heterogeneity as a driver of disease variability in the evolution of myeloproliferative neoplasms. [PDF]

open access: yes, 2014
Myeloproliferative neoplasms (MPNs) are clonal hematological diseases in which cells of the myelo-erythroid lineage are overproduced and patients are predisposed to leukemic transformation.
de Haan, Gerald   +3 more
core   +1 more source

Atypical chronic myeloid leukemia: From diagnosis to molecular features and therapeutic options

open access: yesHemaSphere, Volume 9, Issue 12, December 2025.
ABSTRACT Atypical chronic myeloid leukemia (aCML) is a rare form of myelodysplastic (MDS)/myeloproliferative neoplasm (MPN) overlap disorder characterized by neutrophilic leukocytosis with circulating immature myeloid cells (IMC), frequent hepatosplenomegaly, and poor prognosis with high rates of leukemic transformation.
Alessandra Iurlo   +3 more
wiley   +1 more source

Multiple venous and arterial thromboses of the gallbladder causing acute cholecystitis. A previously undescribed complication of essential thrombocythemia(†)(†)Supported in part by Fundación Clínica Médica Sur.

open access: yesAnnals of Hepatology, 2011
Well established complications of essential thrombocythemia are multiple thrombohemorrhagic phenomena in various abdominal organs. We describe the case of a 22 year old man with essential thrombocythemia and thrombosis of the mesenteric and splenic veins
Gabriela Picón-Coronel   +3 more
doaj   +1 more source

Multiple cardiac surgical procedures in a case of an octogenarian with essential thrombocythemia [PDF]

open access: gold, 2023
Motohiro Maeda   +5 more
openalex   +1 more source

Health‐related quality of life and symptom profile of patients with BCR::ABL1‐negative myeloproliferative neoplasms: Real‐world evidence from the GIMEMA‐PROPHECY observational study

open access: yesHemaSphere, Volume 9, Issue 12, December 2025.
Abstract Health‐related quality of life (HRQoL) of patients with myeloproliferative neoplasms (MPNs) may be impaired across several domains. In this multicenter observational study, we evaluated HRQoL and symptoms in a cohort of MPN patients with validated measures, including the European Organization for Research and Treatment of Cancer Quality of ...
Giovanni Caocci   +26 more
wiley   +1 more source

Patterns of survival among patients with myeloproliferative neoplasms diagnosed in Sweden from 1973 to 2008: a population-based study. [PDF]

open access: yes, 2013
To access publisher full text version of this article. Please click on the hyperlink in Additional Links field.Reported survival in patients with myeloproliferative neoplasms (MPNs) shows great variation.
Andersson, Therese M-L   +7 more
core   +1 more source

Outcomes of Cerebral Venous Thrombosis in Patients With Myeloproliferative Neoplasms from a U.S. Nationwide Hospitalization Study

open access: yes
eJHaem, Volume 7, Issue 1, February 2026.
Nikhil Vojjala   +6 more
wiley   +1 more source

Toe Gangrene as the First Presenting Symptom of Essential Thrombocythemia: A Case Report [PDF]

open access: diamond, 2023
Mahmoud M Altayyan   +7 more
openalex   +1 more source

Essential Thrombocythemia Complicated by Addison's Disease: A Case of Overlapping Endocrine and Hematological Disorders

open access: yesHematology, Transfusion and Cell Therapy
This case report delves into the intricacies of managing a patient diagnosed with both essential thrombocythemia and Addison's disease, illustrating the challenges and importance of an integrated approach to complex, coexisting conditions.
Meryem SENER   +7 more
doaj   +1 more source

Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients

open access: yesHaematologica, 2008
Background Essential thrombocythemia is a chronic myeloproliferative disorder; patients with this disorder have a propensity to develop thrombosis, myelofibrosis, and leukemia.Design and Methods We studied 605 patients with essential thrombocythemia ...
Francesco Passamonti   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy